You're likely referring to Jonas Salk (injected inactivated vaccine, IPV) and Albert Sabin (oral live attenuated vaccine, OPV). Both aimed to prevent polio—not treat it—and both dramatically reduced global cases.
| Salk (IPV) | Sabin (OPV) | |
|---|---|---|
| Virus type | Inactivated (killed) | Live attenuated (weakened) |
| Administration | Injection | Oral drops |
| Protection | Prevents paralytic polio well; less effective against intestinal infection | Prevents infection & paralysis; reduces community spread via contact immunity |
| Challenges | Multiple doses, strict cold chain | Rare reversion to virulence (VAPP) |
| Licensed | 1955 | 1961 |
Salk's IPV brought polio under control in the 1950s; Sabin's OPV enabled global eradication campaigns. Both are still used today in coordinated vaccination schedules.